Associate Director, Intercontinental Real World Evidence (RWE) Lead

The Intercontinental (“Intercon”) Real World Evidence Lead will be responsible for collaborating with affiliate, Area, and International teams in driving evidence generation priorities as defined by the Therapeutic Areas (TA) and aligned with the Area Medical VP, co-leading the development, implementation, and improvement of key cross-functional evidence generation capabilities, and providing methodological expertise and leadership.

Fit-for-Purpose Evidence Generation being one of MHI’s Fundamental Pillars, this role bridges Medical Affairs, Health Impact, and other key cross-functional stakeholders including but not limited to Market Access, Epidemiology, Data Science, and R&D Data Convergence, ultimately co-driving the generation of fit-for-purpose RWE. The Real World Evidence Lead will also keep a dotted-line reporting with MHI’s International RWE Center of Expertise (RWE CoE), serving as Intercon’s RWE Lead and fostering all other relevant internal and external networks, supporting the end-to-end evidence generation process, while ensuring alignment with evolving Real World Data/Evidence (RWD/E) guidelines and trends.

This position will be based from our Mettawa, IL, headquarters location and will follow a hybrid schedule of 3 days/week onsite.

Major Responsibilities:

1. Act as the RWE Community Lead for Intercon; champion the understanding and optimal use of primary and secondary real-world data.
2. Partner closely with Intercon Area and Local Evidence Teams to support the end-to-end evidence generation process, with emphasis on evidence planning and optimal real-world study design aligned with strategic objectives.
3. Support Intercon-level implementation of systems, tools, platforms and processes, inclusive of AI resources, related to evidence generation and local and Area evidence plans, aligned with project RACE (Real World Evidence Activation for Communication Excellence) recommendations and guidance. Importantly, identify Convergence internal and external data opportunities and collaborate with R&D and technology teams to advance complex, innovative research projects.
4. Partner with MHI's RWE Center of Excellence to establish, co-lead, and sustain international and Intercon-focused RWD/E networks and forums. This includes, but is not limited to, pan-TA and TA-specific RWE Community Forums, as well as the International Evidence Network—aligned with agreements made with the Area Medical VP and Intercon TA Heads and Leads.
5. Work collaboratively with Intercon Medical Operations team to ensure timely strategic alignment and technical reviews by relevant Strategic Review Forums (SRF) and Scientific Review Committees (SRC).
6. Deliver training to all levels of the Intercon MHI organization and key cross-functional stakeholders and highlight available resources, as aligned with the Area Medical VP and MHI’s RWE CoE.
7. Represent Intercon as RWD/E Subject Matter Expert (SME) in relevant internal evidence generation workstreams and signature projects, including as Senior Scientific Member for Intercon’s Area Review Committee (ARC).
8. Promote Intercon MHI and relevant cross-functional stakeholders’ awareness, knowledge and acquisition of RWD sources, addressing priority evidence gaps.
9. Evaluate and engage with external vendors/data owners for new evidence generation opportunities.
10. Collaborate with relevant internal teams and working groups (e.g., Data Strategies and Partnership, Epidemiology, Convergence C-DAP, Regulatory Policy Intelligence, etc.) in driving proactive RWD/E-focused academic partnerships and external collaborations, aligned with Intercon’s evidence generation priorities.
11. Stay current with external Regulatory, HTA, Policy Makers and other relevant stakeholders and academic/scientific groups’ RWD/E guidelines, innovations, and trends; represent Intercon in consortia and drive innovative use of RWD.
12. Collaborate and share best practices within International Therapeutics and US RWE lead communities to enhance customer excellence.